Derek K. Chu

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 543 citations · Full text

Cobimetinib Versus Regorafenib, Oncology, Medicine +10

Drug allergy: A 2022 practice parameter update

David A. Khan, Aleena Banerji, Kimberly G. Blumenthal et al. · Journal of Allergy and Clinical Immunology · 2022 · 431 citations

Asthma, Drug Hypersensitivity, Allergy +8

IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization

Derek K. Chu, Alba Llop‐Guevara, Tina D. Walker et al. · Journal of Allergy and Clinical Immunology · 2012 · 333 citations

Inflammation, Allergy, Immunology +9

Oxygen therapy for acutely ill medical patients: a clinical practice guideline

Reed Siemieniuk, Derek K. Chu, Lisa Ha-Yeon Kim et al. · BMJ · 2018 · 282 citations

Upper Limit, Supplemental Oxygen, Hospital Medicine +18

EAACI Biologicals Guidelines—Recommendations for severe asthma

Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş et al. · Allergy · 2020 · 263 citations · Full text